Meijer KA, et al. Predicting conversion to secondary progressive MS: the role of MRI measures. ECTRIMS 2018, P786.
Subcutane toediening kan leiden tot lagere concentraties natalizumab in bloed
feb 2023 | Multipele Sclerose
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen